Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma—correlation with excision repair cross-complementing-1 polymorphisms-Reference-Cited by-同舟云学术

Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma—correlation with excision repair cross-complementing-1 polymorphisms

Published:2009-11 Issue:11 Volume:20 Page:1854-1859
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ma B.B.Y.,Hui E.P.,Wong S.C.C.,Tung S.Y.,Yuen K.K.,King A.,Chan S.L.,Leung S.F.,Kam M.K.,Yu B.K.H.,Zee B.,Chan A.T.C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/11/1854/471441/mdp065.pdf

Reference29 articles.

1. A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma;Yeo;Eur J Cancer,1998

2. A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma;Au;Ann Oncol,1994

3. Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study;Ngan;Ann Oncol,2002

4. A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma;Chua;Oral Oncol,2005

5. Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions;Ma;Cancer Sci,2008

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients;Scientific Reports;2023-10-05

2. Effect of ERCC1 polymorphisms on the response to platinum-based chemotherapy: A systematic review and meta-analysis based on Asian population;PLOS ONE;2023-05-04

3. Traditional Chinese medicine formula 01 for nasopharyngeal carcinoma (NPC01) for head & neck cancer and health-related quality of life: a retrospective study;BMC Complementary Medicine and Therapies;2022-08-10

4. Nasopharyngeal carcinoma in children and adolescents: a literature review and our own data;Pediatric Hematology/Oncology and Immunopathology;2022-06-24

5. An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma;Cancers;2022-04-11